Finance

Lists
Why is 544319 up 4,76%?
Dive Deeper
544319:BOM
Senores Pharmaceuticals Ltd
1 318,00 INR
+4,76%
(+59,90) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544319...
Open
1 258,15 INR
High
1 323,70 INR
Low
1 252,20 INR
Mkt. cap
60,72 მლრდ.
Avg. vol.
29,93 ათ.
Volume
6,41 ათ.
P/E ratio
48,75
52-wk high
1 599,55 INR
52-wk low
708,10 INR
EPS
27,03 INR
No. of employees
368
Open
1 258,15 INR
High
1 323,70 INR
Low
1 252,20 INR
Mkt. cap
60,72 მლრდ.
Avg. vol.
29,93 ათ.
Volume
6,41 ათ.
P/E ratio
48,75
52-wk high
1 599,55 INR
52-wk low
708,10 INR
EPS
27,03 INR
No. of employees
368
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
24 წუთის წინ
Prediction: Oracle Stock Trails the S&P 500 Through 2030
Yahoo Finance
Yahoo Finance
·
47 წუთის წინ
Howard Marks: The S&P 500 isn’t a good bet right now
조선일보
조선일보
·
24 წუთის წინ
SK Hynix Faces Backlash Over Solidigm's $100B Nasdaq Listing
MarketWatch
MarketWatch
·
1 დღის წინ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
About Senores Pharmaceuticals Ltd
CEO-
Employees368
Founded2017
Headquarters-
SectorPharmaceutical industry
Websitesenorespharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,53 მლრდ.
1,65 მლრდ.
1,93 მლრდ.
1,80 მლრდ.
Cost of goods sold
570,80 მლნ.
670,20 მლნ.
748,40 მლნ.
657,20 მლნ.
Cost of revenue
570,80 მლნ.
670,20 მლნ.
748,40 მლნ.
657,20 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
296,30 მლნ.
306,60 მლნ.
365,40 მლნ.
299,10 მლნ.
Operating expense
548,70 მლნ.
517,00 მლნ.
971,90 მლნ.
706,70 მლნ.
Total operating expenses
1,12 მლრდ.
1,19 მლრდ.
1,72 მლრდ.
1,36 მლრდ.
Operating income
414,10 მლნ.
461,40 მლნ.
213,50 მლნ.
438,20 მლნ.
Other non operating income
54,10 მლნ.
37,90 მლნ.
-126,20 მლნ.
28,10 მლნ.
EBT including unusual items
406,30 მლნ.
446,00 მლნ.
474,10 მლნ.
394,60 მლნ.
EBT excluding unusual items
406,30 მლნ.
446,00 მლნ.
467,10 მლნ.
394,60 მლნ.
Income tax expense
105,10 მლნ.
110,20 მლნ.
107,30 მლნ.
90,10 მლნ.
Effective tax rate
25,87%
24,71%
22,63%
22,83%
Other operating expenses
171,50 მლნ.
131,80 მლნ.
513,50 მლნ.
308,20 მლნ.
Net income
323,80 მლნ.
316,60 მლნ.
316,20 მლნ.
307,20 მლნ.
Net profit margin
21,11%
19,20%
16,35%
17,05%
Earnings per share
6,54
7,29
7,96
6,60
Interest and investment income
-
-
140,00 მლნ.
-
Interest expense
-61,90 მლნ.
-53,30 მლნ.
-72,80 მლნ.
-71,70 მლნ.
Net interest expenses
-61,90 მლნ.
-53,30 მლნ.
67,20 მლნ.
-71,70 მლნ.
Depreciation and amortization charges
80,90 მლნ.
78,60 მლნ.
93,00 მლნ.
99,40 მლნ.
EBITDA
484,55 მლნ.
499,80 მლნ.
277,00 მლნ.
516,32 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები